跳至主要内容
临床试验/NCT01404221
NCT01404221终止不适用

The Combination of Biochemical Markers and Two and Three Dimensional Ultrasound Using Geometric Morphometrics in the Identification of Congenital Anomalies and Maternal or Fetal Complications

Northwell Health0 个研究点目标入组 350 人开始时间: 2009年3月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
350
主要终点
Correlation of geometric morphometric analysis of fetal brow to 10 soft markers

研究概览

简要总结

Can a combination of prenatal screening blood tests, early ultrasound, and a 3D ultrasound of the fetal face at approximately 20 weeks gestation identify fetuses with congenital anomalies and predict maternal and fetal complications?

详细描述

Pts will be consented upon presenting to the department for a comprehensive ultrasound.The 3D picture is the only part of the study that is not part of standard obstetrical care.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women at approximately 20 weeks
  • ages 18-50
  • singleton pregnancy
  • plans to deliver at North Shore University Hosp
  • completed step-wise sequential screening

排除标准

  • multifetal gestation
  • patients who have undergone diagnostic genetic testing
  • incarcerated patients
  • intention to deliver at a hospital other than North Shore University hosp

结局指标

主要结局

Correlation of geometric morphometric analysis of fetal brow to 10 soft markers

时间窗: completion of pregnancy

In patients who have undergone step-wise sequential screening, how often will the evaluation of 10 midtrimester sonographic soft markers of aneuploidy such that the recommendation regarding invasive diagnostic testing be changed?

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Burt Rochelson

Investigator, MD

Northwell Health

相似试验